Welcome To Welox Pharma WHO-GMP | ISO 9001:2015

+91 7984303039 inquiry@weloxpharma.com
Translated into: English Spanish Portuguese French
+91 7984303039 inquiry@weloxpharma.com

Category

Show more...

Sorafenet Sorafenib Tosylate Tablets

  • Product Name : Sorafenet Sorafenib Tosylate Tablets
  • Category : Anti Cancer
  • Manufacturer Name : Natco
  • Trade Name : Sorafenet
  • Available Dosage :
  • Packing : Bottle
  • Pack Insert/Leaflet : 1 Pack/120 Tablets
  • Ingredients : Sorafenib
  • Formulation : Tablet
  • Therapeutic use : treatment of patients with locally recurrent or metastatic
  • Production Capacity : 100000

Description:-

Introduction to Sorafenib

Sorafenib is a targeted anti-cancer medication utilized in the management of various malignancies, including liver cancer, kidney cancer, and thyroid cancer. Its formulation is designed to effectively combat tumor growth.


Uses of Sorafenib

Sorafenib is primarily indicated for:

Treatment of hepatocellular carcinoma (liver cancer)

Management of advanced renal cell carcinoma (kidney cancer)

Treatment of differentiated thyroid carcinoma (thyroid cancer)


Benefits of Sorafenib

Targeted Therapy: Specifically designed to inhibit cancer cell growth through targeted action.

Progression Control: Helps slow the progression of cancer, improving patient outcomes.

Clinical Support: Backed by extensive clinical research demonstrating its efficacy and safety.


Mechanism of Action of Sorafenib

Sorafenib operates by blocking the signaling pathways of abnormal proteins associated with cancer cell proliferation. By inhibiting these pathways, Sorafenib effectively disrupts tumor growth and metastasis, providing a strategic advantage in cancer management.